Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schachter, M.
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Low-dose statins: useful and safe?

Mike Schachter

Department of Clinical Pharmacology, National Heart and Lung Institute, Imperial College School of Medicine, St Marys Hospital, London, W2 1NY, UK, m.schachter{at}imperial.ac.uk

This article considers the raison d'être for the use of low-dose statins, their safety, efficacy and potential as non-prescription drugs. It is very much a personal contribution to a controversial area which has become very topical.

Key Words: statins • low-dose • primary prevention • dyslipidaemia • combination therapy.

The British Journal of Diabetes & Vascular Disease, Vol. 4, No. 4, 260-262 (2004)
DOI: 10.1177/14746514040040040801
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?